The Advaxis website seems to be geared towards pediatric regarding HER2. Seems like it may be worth pursuing for a possible priority review voucher for pediatric. Last time I checked I believe 18 year olds we're still considered eligible for pediatric population; not sure how many 18 year olds we may have included in our trial.